Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified

Haematologica

Volumn 94, Issue 7, 2009, Pages 1036-1038

  Gazzola, Anna ^a   Bertuzzi, Clara ^a   Agostinelli, Claudio ^a   Righi, Simona ^a   Pileri, Stefano A ^a   Piccaluga, Pier Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Gene sequencing; Immunohistochemistry; Microarray; Peripheral T cell lymphoma; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENE LOCUS; GENOTYPE; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; T CELL LYMPHOMA; T LYMPHOCYTE; TISSUE MICROARRAY; TRANSCRIPTION REGULATION; TUMOR CLASSIFICATION;

DNA PRIMERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, T-CELL; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 67650718766     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.006718     Document Type: Letter

References (12)

1. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. Editors. WHO Classification of tumors of hematopoietic and lymphoid tissues. IV ed. Lyon; IARC. 2008.
2. Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S, et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol 2008;61:1160-7.
3. Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007;117: 823-34.
4. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006;24:2472-9.
5. Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007;25:3321-9.
6. Butler MP, Wang SI, Chaganti RS, Parsons R, Dalla-Favera R. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 1999;24:322-7.
7. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998; 8:1169-78.
8. Fukuda R, Hayashi A, Utsunomiya A, Nukada Y, Fukui R, Itoh K, et al. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc Natl Acad Sci USA 2005;102:15213-8.
9. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000;95:2937-42.
10. De Keersmaecker K, Marynen P, Cools J. Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 2005;90:1116-27.
11. Uner AH, Saglam A, Han U, Hayran M, Sungur A, Ruacan S. PTEN and p27 expression in mature T-cell and NK-cell neoplasms. Leuk Lymphoma 2005;46:1463-70.
12. Piccaluga PP, Agostinelli C, Righi S, Zinzani PL, Pileri SA. Expression of CD52 in peripheral T-cell lymphoma. Haematologica 2007;92:566-7.